Bone Biologics Announces Private Placement Agreement Worth $3.0 Million
Bone Biologics (BBLG) has entered into a definitive agreement for an at-the-market private placement with a healthcare-focused institutional investor, expected to raise $3.0 million in initial gross proceeds through the sale of 2.11 million shares.
Topics: equity financing private placement